Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 23.13B
December 31, 2025 23.20B
September 30, 2025 23.33B
June 30, 2025 23.20B
March 31, 2025 22.66B
December 31, 2024 22.18B
September 30, 2024 22.64B
June 30, 2024 23.89B
March 31, 2024 23.71B
December 31, 2023 23.20B
September 30, 2023 23.36B
June 30, 2023 23.38B
March 31, 2023 23.20B
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021 18.97B
December 31, 2020 18.69B
September 30, 2020 18.35B
June 30, 2020 17.52B
March 31, 2020 17.44B
Date Value
December 31, 2019 17.45B
September 30, 2019 15.30B
June 30, 2019 15.17B
March 31, 2019 15.03B
December 31, 2018 14.26B
September 30, 2018 13.68B
June 30, 2018 13.35B
March 31, 2018 13.37B
December 31, 2017 13.11B
September 30, 2017 13.02B
June 30, 2017 12.68B
March 31, 2017 12.52B
December 31, 2016 10.68B
September 30, 2016 10.75B
June 30, 2016 10.60B
March 31, 2016 10.53B
December 31, 2015 10.43B
September 30, 2015 10.25B
June 30, 2015 10.13B
March 31, 2015 10.07B
December 31, 2014 10.22B
September 30, 2014 10.24B
June 30, 2014 9.962B
March 31, 2014 9.913B
December 31, 2013 8.049B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 645.76M
Cellectis SA 289.19M
Autolus Therapeutics Plc 527.06M
Akari Therapeutics Plc 33.89M
Evaxion AS 23.64M

Total Assets (Quarterly) Related Metrics